Capsaicin in metabolic syndrome
While tirzepatide helps reduce appetite and calorie intake, your body still needs adequate protein, vitamins, fluids, and regular physical activity to preserve muscle and support normal metabolic function
However, an important distinction often gets overlooked: GLP-1 medications are not approved for Type 1 diabetes and in this population, they may increase the risk of a dangerous complication called euglycemic diabetic ketoacidosis (DKA)
Appetite & energy-intake signaling: GLP-1 CS (Cagrilintide + Semaglutide) combines a GLP-1 receptor agonist with an amylin analog, commonly studied for complementary pathways related to satiety signaling, energy intake regulation, and glycemic-associated biomarkers
As a result, the peptide is often investigated in studies that focus on the integrity of the gastrointestinal tract